Net profit of ERIS Lifesciences declined 18.60% to Rs 83.63 crore in the quarter ended December 2024 as against Rs 102.74 crore during the previous quarter ended December 2023. Sales rose 49.36% to Rs 722.12 crore in the quarter ended December 2024 as against Rs 483.48 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 722.12 | 483.48 | 49 |
| OPM % | 34.66 | 36.30 | - |
| PBDT | 197.36 | 161.59 | 22 |
| PBT | 116.16 | 115.87 | 0 |
| NP | 83.63 | 102.74 | -19 |
Powered by Capital Market - Live News